{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:02:22Z","timestamp":1776787342393,"version":"3.51.2"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s40291-017-0307-7","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T05:18:43Z","timestamp":1509513523000},"page":"115-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Targeting AMPK, mTOR and \u03b2-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6859-1156","authenticated-orcid":false,"given":"Doaa Ali","family":"Abdelmonsif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wessam F.","family":"El-Hadidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina Mohamed","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"issue":"5","key":"307_CR1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5582\/ddt.2015.01047","volume":"9","author":"S Ge","year":"2015","unstructured":"Ge S, Huang D. Systemic therapies for hepatocellular carcinoma. Drug Discov Ther. 2015;9(5):352\u201362.","journal-title":"Drug Discov Ther"},{"issue":"42","key":"307_CR2","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.3748\/wjg.v21.i42.12003","volume":"21","author":"F Bellissimo","year":"2015","unstructured":"Bellissimo F, Pinzone MR, Cacopardo B, Nunnari G. Diagnostic and therapeutic management of hepatocellularcarcinoma. World J Gastroenterol. 2015;21(42):12003\u201321.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"307_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.12816\/0017568","volume":"45","author":"H Sabry Ael","year":"2015","unstructured":"Sabry Ael H, El-Aal AA, Mahmoud NS, Nabil Y, Aziz IZ. An initial indication of predisposing risk of schistosoma mansoni infection for hepatocellular carcinoma. J Egypt Soc Parasitol. 2015;45(2):233\u201340.","journal-title":"J Egypt Soc Parasitol"},{"key":"307_CR4","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908\u201343.","DOI":"10.1016\/j.jhep.2011.12.001"},{"issue":"7","key":"307_CR5","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1586\/17474124.2015.1040763","volume":"9","author":"A Facciorusso","year":"2015","unstructured":"Facciorusso A, Licinio R, Carr BI, Di Leo A, Barone M. MEK 1\/2 inhibitors in the treatment of hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2015;9(7):993\u20131003.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"307_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2015.07.018","volume":"379","author":"L Li","year":"2016","unstructured":"Li L, Wang H. Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 2016;379(2):191\u20137.","journal-title":"Cancer Lett"},{"issue":"Suppl 4","key":"307_CR7","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/ijo.2008.124","volume":"32","author":"D Carling","year":"2008","unstructured":"Carling D, Sanders MJ, Woods A. The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond). 2008;32(Suppl 4):S55\u20139.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"307_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1748-1716.2009.01970.x","volume":"196","author":"B Viollet","year":"2009","unstructured":"Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxford). 2009;196(1):81\u201398.","journal-title":"Acta Physiol (Oxford)"},{"issue":"5","key":"307_CR9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/cas.12633","volume":"106","author":"N Ishijima","year":"2015","unstructured":"Ishijima N, Kanki K, Shimizu H, Shiota G. Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib. Cancer Sci. 2015;106(5):567\u201375.","journal-title":"Cancer Sci"},{"issue":"7","key":"307_CR10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-15-0068","volume":"13","author":"G Zadra","year":"2015","unstructured":"Zadra G, Batista JL, Loda M. Dissecting the dual role of AMPK in cancer: from experimental to human studies. Mol Cancer Res. 2015;13(7):1059.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"307_CR11","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling ingrowth control and disease. Cell. 2012;149(2):274\u201393.","journal-title":"Cell"},{"issue":"10","key":"307_CR12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00109-015-1326-7","volume":"93","author":"D Liko","year":"2015","unstructured":"Liko D, Hall MN. mTOR in health and in sickness. J Mol Med (Berlin). 2015;93(10):1061\u201373.","journal-title":"J Mol Med (Berlin)"},{"issue":"4","key":"307_CR13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2013.11.031","volume":"60","author":"MS Matter","year":"2014","unstructured":"Matter MS, Decaens T, Andersen JB, Thorgeirsson SS. Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. J Hepatol. 2014;60(4):855\u201365.","journal-title":"J Hepatol"},{"issue":"10","key":"307_CR14","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/tri.12372","volume":"27","author":"E Cholongitas","year":"2014","unstructured":"Cholongitas E, Mamou C, Rodriguez-Castro KI, Burra P. Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review. Transpl Int. 2014;27(10):1039\u201349.","journal-title":"Transpl Int"},{"key":"307_CR15","first-page":"1","volume":"7","author":"G Ferr\u00edn","year":"2015","unstructured":"Ferr\u00edn G, Aguilar-Melero P, Rodr\u00edguez-Per\u00e1lvarez M, Montero-\u00c1lvarez JL, de la Mata M. Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepatic Med. 2015;7:1\u201310.","journal-title":"Hepatic Med"},{"issue":"1","key":"307_CR16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13(1):11\u201326.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"307_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","volume":"142","author":"BD White","year":"2012","unstructured":"White BD, Chien AJ, Dawson DW. Dysregulation of Wnt\/beta-catenin signaling in gastrointestinal cancers. Gastroenterology. 2012;142(2):219\u201332.","journal-title":"Gastroenterology"},{"issue":"2","key":"307_CR18","first-page":"415","volume":"26","author":"TY Lai","year":"2011","unstructured":"Lai TY, Su CC, Kuo WW, Yeh YL, Kuo WH, Tsai FJ, et al. \u03b2-Catenin plays a key role in metastasis of human hepatocellular carcinoma. Oncol Rep. 2011;26(2):415\u201322.","journal-title":"Oncol Rep"},{"issue":"2","key":"307_CR19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3748\/wjg.v22.i2.823","volume":"22","author":"V Vilchez","year":"2016","unstructured":"Vilchez V, Turcios L, Marti F, Gedaly R. Targeting Wnt\/\u03b2-catenin pathway in hepatocellular carcinoma treatment. World J Gastroenterol. 2016;22(2):823\u201332.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"307_CR20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3892\/ol.2015.3450","volume":"10","author":"J Wang","year":"2015","unstructured":"Wang J, Gao Q, Wang D, Wang Z, Hu C. Metformin inhibits growth of lung adenocarcinoma cells by inducing apoptosis via the mitochondria-mediated pathway. Oncol Lett. 2015;10(3):1343\u20139.","journal-title":"Oncol Lett"},{"issue":"1","key":"307_CR21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.18632\/oncotarget.6418","volume":"7","author":"X Zhou","year":"2016","unstructured":"Zhou X, Chen J, Yi G, DengM Liu H, Liang M, et al. Metformin suppresses hypoxia-induced stabilization of HIF-1alpha through reprogramming of oxygen metabolism in hepatocellular carcinoma. Oncotarget. 2016;7(1):873\u201384.","journal-title":"Oncotarget"},{"issue":"1","key":"307_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.2014.271","volume":"111","author":"L Alfonso","year":"2014","unstructured":"Alfonso L, Ai G, Spitale RC, Bhat GJ. Molecular targets of aspirin and cancer prevention. Br J Cancer. 2014;111(1):61\u20137.","journal-title":"Br J Cancer"},{"issue":"23","key":"307_CR23","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jnci\/djs452","volume":"104","author":"VV Sahasrabuddhe","year":"2012","unstructured":"Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, et al. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst. 2012;104(23):1808\u201314.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"307_CR24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ejca.2012.09.030","volume":"49","author":"T Veitonmaki","year":"2013","unstructured":"Veitonmaki T, Tammela TL, Auvinen A, Murtola TJ. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. Eur J Cancer. 2013;49(4):938\u201345.","journal-title":"Eur J Cancer"},{"key":"307_CR25","doi-asserted-by":"crossref","unstructured":"Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, et al. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology. 2012;142(7):1504\u201315.e3.","DOI":"10.1053\/j.gastro.2012.02.050"},{"issue":"3","key":"307_CR26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","volume":"7","author":"HA Edmondson","year":"1954","unstructured":"Edmondson HA, Steiner PE. Primary carcinomaof the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7(3):462\u2013503.","journal-title":"Cancer"},{"issue":"4","key":"307_CR27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5858\/arpa.2012-0032-OA","volume":"137","author":"P Leal","year":"2013","unstructured":"Leal P, Garcia P, Sandoval A, Letelier P, Brebi P, Ili C, et al. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis inpatients with gallbladder adenocarcinoma. Arch Pathol Lab Med. 2013;137(4):552\u20137.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"307_CR28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/jcp.52.6.455","volume":"52","author":"JR Jass","year":"1999","unstructured":"Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, Schoch E, et al. Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol. 1999;52(6):455\u201360.","journal-title":"J Clin Pathol"},{"issue":"5","key":"307_CR29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/CEJ.0b013e32833b48a4","volume":"19","author":"M Bonifazi","year":"2010","unstructured":"Bonifazi M, Gallus S, Bosetti C, Polesel J, Serraino D, Talamini R, et al. Aspirin use and pancreatic cancer risk. Eur J Cancer Prev. 2010;19(5):352\u20134.","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"307_CR30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.canlet.2013.09.001","volume":"345","author":"IH Sahin","year":"2014","unstructured":"Sahin IH, Hassan MM, Garrett CR. Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science. Cancer Lett. 2014;345(2):249\u201357.","journal-title":"Cancer Lett"},{"issue":"3","key":"307_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1158\/1541-7786.MCR-15-0360","volume":"14","author":"R Dachineni","year":"2016","unstructured":"Dachineni R, Ai G, Kumar DR, Sadhu SS, Tummala H, Bhat GJ. Cyclin A2 and CDK2 as novel targets of aspirin and salicylic acid: a potential role in cancer prevention. Mol Cancer Res. 2016;14(3):241\u201352.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"307_CR32","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s13277-015-3959-0","volume":"37","author":"G Ai","year":"2016","unstructured":"Ai G, Dachineni R, Muley P, Tummala H, Bhat GJ. Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention. Tumour Biol. 2016;37(2):1727\u201338.","journal-title":"Tumour Biol"},{"key":"307_CR33","doi-asserted-by":"crossref","first-page":"23269","DOI":"10.1038\/srep23269","volume":"6","author":"L Wen","year":"2016","unstructured":"Wen L, Liang C, Chen E, Chen W, Liang F, Zhi X, et al. Regulation of multi-drug resistance in hepatocellular carcinoma cells is TRPC6\/calcium dependent. Sci Rep. 2016;6:23269.","journal-title":"Sci Rep"},{"issue":"2","key":"307_CR34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bjc.6601913","volume":"91","author":"FVN Din","year":"2004","unstructured":"Din FVN, Dunlop MG, Stark LA. Evidence for colorectal cancer cell specificity of aspirin effects on NF\u03baB signalling and apoptosis. Br J Cancer. 2004;91(2):381\u20138.","journal-title":"Br J Cancer"},{"issue":"25","key":"307_CR35","doi-asserted-by":"crossref","first-page":"21208","DOI":"10.18632\/oncotarget.4126","volume":"6","author":"W Yue","year":"2015","unstructured":"Yue W, Zheng X, Lin Y, Yang CS, Xu Q, Carpizo D, et al. Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2. Oncotarget. 2015;6(25):21208\u201324.","journal-title":"Oncotarget"},{"issue":"4","key":"307_CR36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1158\/1535-7163.MCT-08-0631","volume":"8","author":"HU Park","year":"2009","unstructured":"Park HU, Suy S, Danner M, Dailey V, Zhang Y, Li H, et al. AMP-activated protein kinase promotes human prostate cancer cell growth and survival. Mol Cancer Ther. 2009;8(4):733\u201341.","journal-title":"Mol Cancer Ther"},{"issue":"19","key":"307_CR37","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1158\/1078-0432.CCR-13-0203","volume":"19","author":"L Zheng","year":"2013","unstructured":"Zheng L, Yang W, Wu F, Wang C, Yu L, Tang L, et al. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. Clin Cancer Res. 2013;19(19):5372\u201380.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"307_CR38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1741-7007-11-36","volume":"11","author":"DG Hardie","year":"2013","unstructured":"Hardie DG, Alessi DR. LKB1 and AMPK and the cancer-metabolism link: 10\u00a0years after. BMC Biol. 2013;11(1):36.","journal-title":"BMC Biol"},{"issue":"2 Pt A","key":"307_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2014.01.018","volume":"356","author":"B Faubert","year":"2015","unstructured":"Faubert B, Vincent EE, Poffenberger MC, Jones RG. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator. Cancer Lett. 2015;356(2 Pt A):165\u201370.","journal-title":"Cancer Lett"},{"issue":"1","key":"307_CR40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/cbt.10.1.12162","volume":"10","author":"K Laderoute","year":"2010","unstructured":"Laderoute K, Calaoagan JM, Madrid PB, Klon AE, Ehrlich PJ. SU11248 (sunitinib) directly inhibits the activity of mammalian 5\u2032-AMP-activated protein kinase (AMPK). Cancer Biol Ther. 2010;10(1):68\u201376.","journal-title":"Cancer Biol Ther"},{"issue":"Pt 1","key":"307_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1113\/jphysiol.2006.108324","volume":"574","author":"H Motoshima","year":"2006","unstructured":"Motoshima H, Goldstein BJ, Igata M, Araki E. AMPK and cell proliferation\u2014AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol. 2006;574(Pt 1):63\u201371.","journal-title":"J Physiol"},{"issue":"3","key":"307_CR42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fon.09.174","volume":"6","author":"Z Luo","year":"2010","unstructured":"Luo Z, Zang M, Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 2010;6(3):457\u201370.","journal-title":"Future Oncol"},{"key":"307_CR43","first-page":"2845","volume":"9","author":"Y Sun","year":"2016","unstructured":"Sun Y, Tao C, Huang X, He H, Shi H, Zhang Q, et al. Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK\/p53\/miR-23a\/FOXA1 pathway. OncoTargets and Ther. 2016;9:2845\u201353.","journal-title":"OncoTargets and Ther"},{"issue":"1","key":"307_CR44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3892\/mmr.2015.4513","volume":"13","author":"W Jo","year":"2016","unstructured":"Jo W, Yu ES, Chang M, Park HK, Choi HJ, Ryu JE, et al. Metformin inhibits early stage diethylnitrosamine induced hepatocarcinogenesis in rats. Mol Med Rep. 2016;13(1):146\u201352.","journal-title":"Mol Med Rep"},{"issue":"2","key":"307_CR45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2014.01.018","volume":"356","author":"B Faubert","year":"2015","unstructured":"Faubert B, Vincent EE, Poffenberger MC, Jones RG. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator. Cancer Lett. 2015;356(2):165\u201370.","journal-title":"Cancer Lett"},{"issue":"4","key":"307_CR46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.tp.0000252780.42104.95","volume":"83","author":"W Sieghart","year":"2007","unstructured":"Sieghart W, Fuereder T, Schmid K, Cejka D, Werzowa J, Wrba F, et al. Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation. Transplantation. 2007;83(4):425\u201332.","journal-title":"Transplantation"},{"issue":"6","key":"307_CR47","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1053\/j.gastro.2008.08.008","volume":"135","author":"A Villanueva","year":"2008","unstructured":"Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, et al. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology. 2008;135(6):1972\u201383 (83.e1\u201311).","journal-title":"Gastroenterology."},{"issue":"2","key":"307_CR48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2008.08.018","volume":"273","author":"KH Tam","year":"2009","unstructured":"Tam KH, Yang ZF, Lau CK, Lam CT, Pang RW, Poon RT. Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma. Cancer Lett. 2009;273(2):201\u20139.","journal-title":"Cancer Lett"},{"issue":"13","key":"307_CR49","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","volume":"71","author":"I Ben Sahra","year":"2011","unstructured":"Ben Sahra I, Regazzetti C, Robert G, Laurent K, Le Marchand-Brustel Y, Auberger P, et al. Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res. 2011;71(13):4366\u201372.","journal-title":"Cancer Res"},{"issue":"5","key":"307_CR50","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY, Gulati P, Brule S, Viollet B, et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metab. 2010;11(5):390\u2013401.","journal-title":"Cell Metab"},{"issue":"2","key":"307_CR51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20150122","volume":"469","author":"AJ O\u2019Brien","year":"2015","unstructured":"O\u2019Brien AJ, Villani LA, Broadfield LA, Houde VP, Galic S, Blandino G, et al. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis. Biochem J. 2015;469(2):177\u201387.","journal-title":"Biochem J"},{"issue":"5","key":"307_CR52","first-page":"1273","volume":"39","author":"S Marimuthu","year":"2011","unstructured":"Marimuthu S, Chivukula RS, Alfonso LF, Moridani M, Hagen FK, Bhat GJ. Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: identification of novel targets. Int J Oncol. 2011;39(5):1273\u201383.","journal-title":"Int J Oncol"},{"issue":"2","key":"307_CR53","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3892\/mmr.2016.5449","volume":"14","author":"G Ai","year":"2016","unstructured":"Ai G, Dachineni R, Kumar DR, Alfonso LF, Marimuthu S, Bhat GJ. Aspirin inhibits glucose6phosphate dehydrogenase activity in HCT 116 cells through acetylation: identification of aspirin-acetylated sites. Mol Med Rep. 2016;14(2):1726\u201332.","journal-title":"Mol Med Rep"},{"issue":"9","key":"307_CR54","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1940-6207.CAPR-10-0055","volume":"3","author":"RM Memmott","year":"2010","unstructured":"Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA. Metformin prevents tobacco carcinogen-induced lung tumorigenesis. Cancer Prev Res (Philadelphia, PA). 2010;3(9):1066\u201376.","journal-title":"Cancer Prev Res (Philadelphia, PA)"},{"issue":"3","key":"307_CR55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/jrr\/rrt131","volume":"55","author":"EH Kim","year":"2014","unstructured":"Kim EH, Kim M-S, Cho C-K, Jung W-G, Jeong YK, Jeong J-H. Low and high linear energy transfer radiation sensitization of HCC cells by metformin. J Radiat Res. 2014;55(3):432\u201342.","journal-title":"J Radiat Res"},{"issue":"4","key":"307_CR56","doi-asserted-by":"crossref","first-page":"e93256","DOI":"10.1371\/journal.pone.0093256","volume":"9","author":"J Cheng","year":"2014","unstructured":"Cheng J, Huang T, Li Y, Guo Y, Zhu Y, Wang Q, et al. AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma. PLoS One. 2014;9(4):e93256.","journal-title":"PLoS One"},{"issue":"5","key":"307_CR57","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3892\/or.2013.2718","volume":"30","author":"X Cai","year":"2013","unstructured":"Cai X, Hu X, Cai B, Wang Q, Li Y, Tan X, et al. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1\/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo. Oncol Rep. 2013;30(5):2449\u201357.","journal-title":"Oncol Rep"},{"issue":"1","key":"307_CR58","first-page":"325","volume":"41","author":"L Gao","year":"2012","unstructured":"Gao L, Williams JL. Nitric oxide-donating aspirin inducesG2\/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins. Int J Oncol. 2012;41(1):325\u201330.","journal-title":"Int J Oncol"},{"key":"307_CR59","doi-asserted-by":"crossref","first-page":"45184","DOI":"10.1038\/srep45184","volume":"7","author":"D Tewari","year":"2017","unstructured":"Tewari D, Majumdar D, Vallabhaneni S, Bera AK. Aspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC). Sci Rep. 2017;7:45184.","journal-title":"Sci Rep"},{"issue":"49","key":"307_CR60","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1038\/sj.onc.1209658","volume":"25","author":"CL Bos","year":"2006","unstructured":"Bos CL, Kodach LL, van den Brink GR, Diks SH, van Santen MM, Richel DJ, et al. Effect of aspirin on the Wnt\/\/[beta]-catenin pathway is mediated via protein phosphatase 2A. Oncogene. 2006;25(49):6447\u201356.","journal-title":"Oncogene"},{"issue":"4","key":"307_CR61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1940-6207.CAPR-12-0053","volume":"5","author":"N Subramaniam","year":"2012","unstructured":"Subramaniam N, Sherman MH, Rao R, Wilson C, Coulter S, Atkins AR, et al. Metformin-mediated bambi expression in hepatic stellate cells induces prosurvival Wnt\/\u03b2-catenin signaling. Cancer Prev Res. 2012;5(4):553\u201361.","journal-title":"Cancer Prev Res"},{"issue":"3","key":"307_CR62","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7314\/APJCP.2015.16.3.1281","volume":"16","author":"AR Zekri","year":"2015","unstructured":"Zekri AR, Youssef AS, Bakr YM, Gabr RM, El-Rouby MN, Hammad I, et al. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients. Asian Pac J Cancer Prev. 2015;16(3):1281\u20137.","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Molecular Diagnosis &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-017-0307-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-017-0307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-017-0307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T22:51:09Z","timestamp":1603234269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-017-0307-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1007\/s40291-017-0307-7","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]}}}